Opiant Pharmaceuticals Inc (OPNT) Return on Investment ROI from the third quarter of 2022 to third quarter of 2021 and for the year 2022, average high and low, overall ranking from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Opiant Pharmaceuticals Inc   (NASDAQ: OPNT)


Opiant Pharmaceuticals Inc's ROI from its third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Opiant Pharmaceuticals Inc's ROI in the third quarter of 2022?
Opiant Pharmaceuticals Inc recorded a cumulative net loss of $-33 million during 12 months ending in the third quarter of 2022, resulting in a negative return on investment (ROI) of -72.89%.

Within the Healthcare sector 735 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2022 from 0 to 4770.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Investment Change TTM -19.13 % 4.96 % 24.67 % 48.18 % 62.3 %
Y / Y Net Income Change TTM - - - 7536.72 % 116.68 %
Investment (TTM) in Millions 35 44 39 64 62
Return On Investment (TTM) -72.89 % -37.94 % -11.49 % 5.14 % 2.8 %
OPNT's Overall Ranking # 4770 # 0 # 0 # 2103 # 1972
Seq. Investment Change TTM -12.83 % -5.51 % -5.77 % 4.18 % 13.14 %
Seq. Net Income Change TTM - - - 91.53 % -
Net Income (TTM) in Millions -33 -20 -6 3 2

OPNT Company Profile >> Back to OPNT Roi Comparisons >> See Annual OPNT Return On Investment



Return On Investment OPNT's Ranking
Within: No.
Industry # 324
Sector # 736
Overall # 4770

Return On Investment Statistics
High Average Low
652.51 %
16.02 %
-128.68 %
(Jan 31 2017)   (Dec 31 2018)







Financial Statements
Opiant Pharmaceuticals Inc's III. Quarter Investments $ 35 Millions OPNT's Balance sheet
Opiant Pharmaceuticals Inc's III. Quarter Income $ -10 Millions Quarterly OPNT's Income Statement
OPNT's Income by Division See OPNT's Income by Division


OPNT Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 64 54 35 20 15
Y / Y Investment Growth 17.33 % 56.31 % 77.26 % 29.39 % -
Net Income in Millions 3 -2 12 -21 7
Y / Y Net Income Growth - - - - -
Annual Return On Investment 4.73 % -3.43 % 33.44 % -108.36 % 43.53 %


Annual Roi Comment
In the fiscal year 2021 ROI improved to 4.73 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OPNT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OPNT's Competitors
Subscribers only: Roi for Opiant Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for OPNT's Customers

Other Ratios
OPNT's Roa OPNT's Inventory Turnover Ratio OPNT's Growth Rates OPNT's Dividend Statistics
OPNT's Profitability Ratios OPNT's Asset Turnover Ratio OPNT's Dividend Growth
OPNT's Roe OPNT's Valuation Ratios OPNT's Financial Strength Ratios OPNT's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2022, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.